Novartis AG Free Cash Flow Generation Index
Novartis AG free cash flow generation index. Novartis AG (NVSN) has a Free Cash Flow Generation Index of 0.78x as of March 2026. Free cash flow of MX$2.87 Billion represents 1% of operating cash flow (MX$3.68 Billion).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Novartis AG (2014–2025)
Free cash flow generation index of Novartis AG from 2014 to 2025. Historical FCF Generation Index trend for Novartis AG across 12 annual periods. See Novartis AG (NVSN) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Novartis AG Free Cash Flow Generation Index by Year (2014–2025)
Novartis AG free cash flow generation index by year from 2014 to 2025. Year-by-year Free Cash Flow Generation Index for Novartis AG. For the full cash flow conversion analysis, see NVSN operating cash flow.
| Year | FCG Index | Free Cash Flow (MXN) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.80x | MX$15.24 Billion | MX$19.14 Billion | MX$3.90 Billion | ▲ +1.6% |
| 2024 | 0.78x | MX$13.80 Billion | MX$17.62 Billion | MX$3.81 Billion | ▼ -4.3% |
| 2023 | 0.82x | MX$13.12 Billion | MX$16.02 Billion | MX$2.90 Billion | ▲ +0.8% |
| 2022 | 0.81x | MX$11.56 Billion | MX$14.24 Billion | MX$1.20 Billion | ▲ +1.2% |
| 2021 | 0.80x | MX$12.10 Billion | MX$15.07 Billion | MX$1.38 Billion | ▼ -1.0% |
| 2020 | 0.81x | MX$11.06 Billion | MX$13.65 Billion | MX$1.27 Billion | ▼ -2.8% |
| 2019 | 0.83x | MX$11.37 Billion | MX$13.62 Billion | MX$1.38 Billion | ▲ +9.1% |
| 2018 | 0.76x | MX$10.92 Billion | MX$14.27 Billion | MX$1.25 Billion | ▼ -2.2% |
| 2017 | 0.78x | MX$9.88 Billion | MX$12.62 Billion | MX$1.32 Billion | ▼ -37.5% |
| 2016 | 1.25x | MX$14.35 Billion | MX$11.47 Billion | MX$2.88 Billion | ▲ +4.3% |
| 2015 | 1.20x | MX$14.26 Billion | MX$11.90 Billion | MX$2.37 Billion | ▲ +0.9% |
| 2014 | 1.19x | MX$16.52 Billion | MX$13.90 Billion | MX$2.62 Billion | — |